Jeff Yass’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,487
Closed -$18.7K 13773
2023
Q1
$18.7K Buy
+15,487
New +$16.3K ﹤0.01% 12070
2022
Q2
Sell
-7,772
Closed -$39K 14529
2022
Q1
$39K Buy
+7,772
New +$39.3K ﹤0.01% 12422
2021
Q4
Sell
-573
Closed -$9K 14339
2021
Q3
$9K Buy
+573
New +$9.7K ﹤0.01% 12613
2020
Q2
Sell
-170
Closed -$11K 11265
2020
Q1
$11K Buy
+170
New +$13.3K ﹤0.01% 10043
2019
Q3
Sell
-204
Closed -$11K 11080
2019
Q2
$11K Sell
204
-448
-69% -$77.7K ﹤0.01% 10068
2019
Q1
$141K Buy
652
+43
+7% +$17.3K ﹤0.01% 8095
2018
Q4
$211K Sell
609
-369
-38% -$287K ﹤0.01% 7637
2018
Q3
$1.14M Buy
978
+820
+519% +$755K ﹤0.01% 4984
2018
Q2
$135K Sell
158
-51
-24% -$42.4K ﹤0.01% 8913
2018
Q1
$246K Buy
+209
New +$231K ﹤0.01% 7967
2017
Q2
Sell
-167
Closed -$203K 10061
2017
Q1
$192K Buy
167
+15
+10% +$14.5K ﹤0.01% 8037
2016
Q4
$160K Buy
152
+22
+17% +$9.98K ﹤0.01% 8811
2016
Q3
$52K Buy
+130
New +$53K ﹤0.01% 8111
2016
Q2
Sell
-74
Closed -$36.2K 9571
2016
Q1
$32K Sell
74
-191
-72% -$73.8K ﹤0.01% 8757
2015
Q4
$153K Buy
265
+73
+38% +$51.1K ﹤0.01% 8642
2015
Q3
$171K Buy
192
+124
+182% +$113K ﹤0.01% 8826
2015
Q2
$70K Buy
+68
New +$79.7K ﹤0.01% 9789
2015
Q1
Sell
-200
Closed -$254K 10114
2014
Q4
$280K Sell
200
-273
-58% -$394K ﹤0.01% 8248
2014
Q3
$579K Buy
+473
New +$680K ﹤0.01% 6948

Other funds holding HSTO

Jeff Yass's HSTO Position: Q2 2023 in Review

Jeff Yass sold out of Histogen Inc. Common Stock (HSTO) in Q2 2023, closing a stake of 15,487 shares — an estimated $18.7K sold.

Jeff Yass first reported a position in HSTO in Q3 2014 and held it in 19 quarters. The position peaked at $1.14M in Q3 2018. 13 funds tracked by Wall St. Rank hold HSTO as of Q2 2023.

  • Jeff Yass reported no remaining Histogen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jeff Yass sold 15,487 Histogen Inc. Common Stock shares in Q2 2023, an estimated $18.7K.
  • Jeff Yass first reported a position in Histogen Inc. Common Stock in Q3 2014 and held it in 19 quarters.
  • Jeff Yass's Histogen Inc. Common Stock position peaked at $1.14M in Q3 2018.
  • 13 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.